ANO1 and aneurysmal bone cyst: DNA sequencing and immunohistochemistry (H3.3 mutation-specific antibodies, DOG1) of all 19 ABC cases included in our study revealed no mutation in H3F3A/B and showed no positive IHC staining, ruling out secondary ABC on the basis of GCT or CB.